Alere™ PBP2a SA Culture Colony Test by Alere Inc

Manufacturer Alere Inc  |   Model: 893-000
5.0
/
5.0
  |  2 reviews
A rapid immuno-chromatographic assay that uses monoclonal antibodies to assist in the detection of MRSA directly from bacterial isolates in five minutes.


Alere™ PBP2a SA Culture Colony Test by Alere Inc product image
Alere™ PBP2a SA Culture Colony Test
Request Pricing

Receive your quote directly from the manufacturer.




Average Rating: 5.0
2 Scientists have reviewed this product

5 out of 5
Ease of use
5 out of 5
After sales service
5 out of 5
Value for money


Excellent product, simple to use, easy to interpret.
Rating: 5.0

  • Application Area: Rapid MRSA determination

"One of the easiest kit tests we use in the lab. Currently we are performing this test on SA colonies from blood cultures/sterile sites, and nasal MRSA screening. PBP results match almost perfectly with other testing methods used. While I would personally prefer a same day rapid test to use for our nasal MRSA screening, finances side with the culture/PBP test in our patient payer mix."

Review date: 01 Apr 2017 | Alere™ PBP2a SA Culture Colony Test
  • Status:

    Reviewer

  • Member since: 2015

  • Organization: MW Medical Associates.



  • Ease of use
    5 out of 5
    After sales service
    5 out of 5
    Value for money
    5 out of 5
Works fast with accurate results.
Rating: 5.0

  • Application Area:Analyze bacteria and blood in urine

"Alere is one of the best products I use in my lab I have many Alere products. Love the accuracy, speed and service from the company. Always a great experience."

Review date: 08 Dec 2015 | Alere™ PBP2a SA Culture Colony Test

The new Alere™ PBP2a SA Culture Colony Test is a rapid immuno-chromatographic assay that uses monoclonal antibodies to assist in the detection of MRSA directly from bacterial isolates in five minutes. In a U.S. study, results were available at least one day sooner than standard antimicrobial susceptibility tests, and were used to effectively modify and improve treatment regimens for patients with S. aureus infections.